Brand Intelligence Graphcompany
Company Overview
About Generate Biomedicines
Generate Biomedicines is a clinical-stage biotech founded in 2018 by Flagship Pioneering, headquartered in Somerville, Massachusetts. The company pioneers generative biology, using ML and large-scale experimental systems to design protein therapeutics. Its platform combines diffusion and graph-based AI models with high-throughput biohardware. The pipeline spans immunology, oncology, and infectious diseases.
Business Model & Competitive Advantage
Generate's model combines internal drug development with collaboration revenue from Amgen and Novartis. Lead program GB-0895, a long-acting anti-TSLP antibody engineered for every-six-month dosing, is in Phase 3 for severe asthma with FDA Fast Track designation (January 2026). It competes with Recursion Pharmaceuticals and Absci.
Competitive Landscape 2025–2026
Generate went public on Nasdaq in February 2026 under ticker GENB, raising approximately $400 million. 2025 collaboration revenue was $31.89 million against a $222.97 million net loss. With 312 employees, the company is advancing its Phase 3 program and expanding its generative biology platform.
Recent Activity
View all →Key Differentiators
Strong Challenger
Generate Biomedicines is an established challenger with significant market presence and competitive offerings in Healthcare Tech.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
Idexx Laboratories
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headqu
Revvity
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provid
GE HealthCare
GE HealthCare Technologies Inc. is a Chicago, Illinois-based medical technology and digital health company — publicly traded on the NASDAQ (NASDAQ: GEHC) as an S&P 500 Health Care component — designin
Incyte
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company — publicly traded on the NASDAQ (NASDAQ: INCY) as an S&P 500 Health Care component — focused on oncology and inflammation,
Biogen
Biogen Inc. is a Cambridge, Massachusetts-based neuroscience biopharmaceutical company — publicly traded on NASDAQ (NASDAQ: BIIB) as an S&P 500 Health Care component — researching, developing, and com
Compare Generate Biomedicines with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Generate Biomedicines? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Generate Biomedicines Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Generate Biomedicines vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →